Cited by 230Dementia and Cognitive Impairment ResearchCancer-related cognitive impairment studiesAlzheimer's disease research and treatments

Depression, Apolipoprotein E Genotype, and the Incidence of Mild Cognitive Impairment: A Prospective Cohort Study

Geda, Yonas E., Knopman, David S., Mrazek, David A., Jicha, Gregory A., Smith, Glenn E., Negash, Selamawit, Boeve, Bradley F., Ivnik, Robert J. +3 more·2006·Archives of Neurology

Abstract

BACKGROUND: It remains unknown whether depression and apolipoprotein E genotype are risk factors for incident mild cognitive impairment (MCI). OBJECTIVE: To determine whether elderly individuals with depression (measured by the short Geriatric Depression Scale) are at increased risk of developing incident MCI. DESIGN: Prospective cohort study. SETTING: Primary care clinic. PARTICIPANTS: A cohort of 840 cognitively normal elderly subjects without depression at recruitment who were followed up prospectively for a median of 3.5 years (range, 0.4-12.8 years). Subjects who developed depression (score of >/=6 on the short Geriatric Depression Scale; depression cohort) were compared with all remaining subjects (referent cohort). MAIN OUTCOME MEASURES: Incidence of MCI (primary outcome) and incidence of MCI or dementia (composite secondary outcome). RESULTS: Individuals in the depression cohort were at significantly increased risk of subsequent incident MCI (hazard ratio [HR], 2.2; 95% confidence interval [CI], 1.2-4.1) after adjusting for age (time scale), sex, and education, and considering dementia as a competing outcome. The association was stronger in men but did not vary by severity of depression. We observed a synergistic interaction between apolipoprotein E genotype (epsilon3/epsilon4 or epsilon4/epsilon4) and depression (joint effect HR, 5.1; 95% CI, 1.9-13.6; test for additive interaction, P = .03). We found a similar association between depression and the subsequent composite outcome of incident MCI or dementia (HR, 2.6; 95% CI, 1.6-4.3). CONCLUSIONS: Cognitively normal elderly individuals who develop depression are at increased risk of subsequent MCI. We found a synergistic interaction between depression and apolipoprotein E genotype.

Integrity signals

Registry

Crossref · 10.1001/archneur.63.3.435

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Depression is characterized not only by feelings of sadness and worthlessness, but also by inertia, lethargy, and impaired cognition that is more prevalent in the elderly.

    “Depression is characterized not only by feelings of sadness and worthlessness, but also by inertia, lethargy, and impaired cognition that is more prevalent in the elderly (Geda et al., 2006) (Jorm, 2000; Kumar et al., 2006).”
  • In humans, the incidence of depression and impairments in cognitive function, most notably spatial memory, are higher among the elderly.

    “In humans, the incidence of depression and impairments in cognitive function, most notably spatial memory, are higher among the elderly (Geda et al, 2006; Jorm, 2000; Kumar et al., 2006).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Geda, Y. E., Knopman, D. S., Mrazek, D. A., Jicha, G. A., Smith, G. E., Negash, S., Boeve, B. F., Ivnik, R. J., Petersen, R. C., Pankratz, V. S., & Rocca, W. A.
Affiliations
Mayo Clinic (US)
Venue
Archives of Neurology
Published
2006-03-01
Volume
63
Issue
3
Pages
435
ISSN
0003-9942 (ISSN-L)
OpenAlex
W2167153475
Cited by
230
References
36
Citations by year
2026: 2 · 2025: 7 · 2024: 6 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 8 · 2019: 8 · 2018: 14 · 2017: 6 · 2016: 12 · 2015: 12 · 2014: 12 · 2013: 10 · 2012: 21
FWCI
10.41
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Neurology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Mayo Clinic
  • National Institute on Aging (P50‐AG16574, U01AG06786, U01AG006786, P50AG016574)
  • National Institute of Mental Health (K01-MH68351, K01MH068351)
  • National Institute of Neurological Disorders and Stroke (R01-NS33978, R01NS033978)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
depression, APOE genotype, mild cognitive impairment, dementia, older adults, Geriatric Depression Scale, genetic risk factors, synergistic interaction, cognitive decline
MeSH terms
Aged, Aged, 80 and over, Apolipoproteins E, Cognition Disorders, Demography, Depression, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prospective Studies, Risk, Geriatric Assessment, Incidence, Proportional Hazards Models, Survival Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review